Mischa Woisetschläger

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Contrast Enhanced

Postmenopausal Women

Top Venues

European radiology experimental

Archives of osteoporosis

SAGE open medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mischa Woisetschläger, Ronald Booij, Erik Tesselaar, Edwin H G Oei, Jörg Schilcher
Improved visualization of the bone-implant interface and osseointegration in ex vivo acetabular cup implants using photon-counting detector CT. European radiology experimental 7 (1) (2023)
Mischa Woisetschläger, Ronald Booij, Erik Tesselaar, Edwin H G Oei, Jörg Schilcher
Improved visualization of the bone-implant interface and osseointegration in ex vivo acetabular cup implants using photon-counting detector CT. European radiology experimental 7 (1) (2023)
Mischa Woisetschläger, Ronald Booij, Erik Tesselaar, Edwin H G Oei, Jörg Schilcher
Improved visualization of the bone-implant interface and osseointegration in ex vivo acetabular cup implants using photon-counting detector CT. European radiology experimental 7 (1) (2023)
Mischa Woisetschläger, Ronald Booij, Erik Tesselaar, Edwin H G Oei, Jörg Schilcher
Improved visualization of the bone-implant interface and osseointegration in ex vivo acetabular cup implants using photon-counting detector CT. European radiology experimental 7 (1) (2023)
Mischa Woisetschläger, Eva Klintström, Anna Spångeus
The impact of imaging time and contrast agent dose on screening for osteoporosis with contrast-enhanced CT. European radiology experimental 6 (1) (2022)
Mischa Woisetschläger, Simona Chisalita, Marta Vergara, Anna Spångeus
Selection of risk assessment methods for osteoporosis screening in postmenopausal women with low-energy fractures: A comparison of fracture risk assessment tool, digital X-ray radiogrammetry, and dual-energy X-ray absorptiometry. SAGE open medicine 10 (2022)
Anna Spångeus, Simon Johansson, Mischa Woisetschläger
Adherence to and persistence with zoledronic acid treatment for osteoporosis-reasons for early discontinuation. Archives of osteoporosis 15 (1) (2020)